Article
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
BMC infectious diseases - 2 Aug 2013
Kristiansen Paul A, Ba Absatou Ky, Sanou Idrissa, Ouédraogo Abdoul-Salam, Ouédraogo Rasmata, Sangaré Lassana, Diomandé Fabien, Kandolo Denis, Thomas Jennifer Dolan, Clark Thomas A, Laforce Marc, Caugant Dominique A
Abstract excerpt
BACKGROUND: The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of the 1-29-year-olds in Burkina Faso in 2010. The aim of this study was to genetically characterize meningococcal isolates circulating in Burkina Faso before and up to 13 months after MenAfriVac mass vaccination. METHODS: A total of 1,659 meningococcal carriage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
